Bupropion (xl) Per recalls

The FDA has published 3 recalls involving Bupropion (xl) Per since 2013. The latest was reported on 4 Sep 2013. Most were for potency & assay. Actavis South Atlantic has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2013

Last 12 months0reported

Class I00% of total

Ongoing0latest 4 Sep 2013

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 3 100%

Why bupropion (xl) per is recalled

Potency & Assay3100%

Companies

Actavis South Atlantic267%
Actavis133%

By year

20133100%

All bupropion (xl) per recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
4 Sep 2013Drug	CLASS III	buPROPion Hydrochloride Extended-Release Tablets (XL) recalled	Actavis South Atlantic	Potency & Assay	Nationwide
14 Aug 2013Drug	CLASS III	BuPROPion Hydrochloride Extended-Release Tablets (XL) recalled	Actavis	Potency & Assay	Nationwide
24 Apr 2013Drug	CLASS III	buPROPion Hydrochloride Extended-Release Tablets (XL) recalled	Actavis South Atlantic	Potency & Assay	Nationwide

Should you stop taking Bupropion (xl) Per?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.